ANDA 40882, held by Amneal Pharms. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40882 (Promethazine Hydrochloride), held by Amneal Pharms, was first approved by FDA on Dec 30, 2009, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 30, 2009 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride6.25MG/5ML ยท syrup;oral | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters